About SYBLEU

SYBLEU, Inc. (OTC PINK: SYBE) is a biotechnology company committed to advancing healthcare for humans and animals. Our dedication lies in the development and commercialization of therapies, medical devices, and clinical diagnostics. We actively pursue strategic acquisitions and in-licensing opportunities to expand our intellectual property portfolio and seek strategic partnerships to bring these technologies to market.

About SYBLEU

SYBLEU, Inc. (OTC PINK: SYBE) is a leading biotechnology company committed to advancing healthcare for humans and animals. Our dedication lies in the development and promotion of therapies, medical devices, and clinical diagnostics. To expand our intellectual property portfolio, we actively seek strategic acquisitions and in-licensing prospects. Moreover, we facilitate financing and establish strategic partnerships to ensure the successful market introduction of these innovative technologies. At SYBLEU, we assemble proficient senior management teams to achieve our objectives.

Putting together the brightest minds involved in drug development, medical device innovation and cutting edge diagnostics to promote animal and human health as rapidly as possible.

Putting together the brightest minds involved in drug development, medical device innovation and cutting edge diagnostics to promote animal and human health as rapidly as possible.

Our Team

Management Team

Joe Vaini

CEO

Joseph G. Vaini has more than twenty five years experience assisting microcap com...
Headshot

Joe Vaini

CEO

Joseph G. Vaini has more...
Joseph G. Vaini has more than twenty five years...

Harry Lander, Ph.D.

CSO

Dr. Lander has over 30 years of professional scientific, business and financial m...
HL Picture

Harry Lander, Ph.D.

CSO

Dr. Lander has over 30...
Dr. Lander has over 30 years of professional sc...

Joe Vaini

CEO

Joseph G. Vaini has more than twenty five years experience assisting microcap com...
Headshot

Joe Vaini

CEO

Joseph G. Vaini has more...
Joseph G. Vaini has more than twenty five years...

Harry Lander, Ph.D.

CSO

Dr. Lander has over 30 years of professional scientific, business and financial m...
HL Picture

Harry Lander, Ph.D.

CSO

Dr. Lander has over 30...
Dr. Lander has over 30 years of professional sc...

Advisory Board

Tom Donnelly, D.V.M.

Dr. Donnelly is a certified specialist in the field of laboratory animal medicine, a major specialty within the veterinary medical profession.  Dr. Donnelley...
20210524-134816_orig

Tom Donnelly, D.V.M.

Dr. Donnelly is a certified specialist in the field of laboratory animal medicine, a ...

Tom Donnelly, D.V.M.

Dr. Donnelly is a certified specialist in the field of laboratory animal medicine, a major specia...

Jason Garber, M.D.

Dr. Garber is a board certified neurosurgeon with Las Vegas Neurosurgical Institute, where he concentrates on the treatment of complex spinal disorders, as w...
20210524-134816_orig

Jason Garber, M.D.

Dr. Garber is a board certified neurosurgeon with Las Vegas Neurosurgical Institute, ...

Jason Garber, M.D.

Dr. Garber is a board certified neurosurgeon with Las Vegas Neurosurgical Institute, where he con...

Steven Hake, M.D.

Dr. Hake is a board certified radiologist with extensive experience assessing and developing diagnostics and medical devices.  Dr. Hake received his M.D. deg...
20210524-134816_orig

Steven Hake, M.D.

Dr. Hake is a board certified radiologist with extensive experience assessing and dev...

Steven Hake, M.D.

Dr. Hake is a board certified radiologist with extensive experience assessing and developing diag...

Intellectual Property

Patent filter2
Patent / Application NumberTitlePatent Type
US 2022/0168240 A1CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATI...
Pending
US 2022/0031912 A1Quality of a cellular graft
Pending
Patent / Application NumberTitlePatent Type
US 2022/0168240 A1CANCER THERAPY BY INTRATUMORAL INJECTION OF A CHEMOTHERAPEUTIC AGENT IN COMBINATI...
Pending
US 2022/0031912 A1Quality of a cellular graft
Pending